2024-10-19 12:44:13
Live from ASCO 2023 | Updated Data of Olverembatinib in SDH-Deficient GIST including a CBR of 93.8% Signals a Potential Clinical Breakthrough
Corporate/ 2023-07-24
Live from ASCO 2023 | Updated Data of Ol...

SUZHOU,China and ROCKVILLE,Md.,June 5,2023--Ascentage Pharma (6855.HK),a global biopharmaceutical company engaged in developing novel therap...

Gencurix Announces Clinical Research Results At ASCO 2023 Demonstrating Outstanding Performance of GenesWell BCT, the Company's Breast Cancer Prognostic Test, Compared to Global Best-Selling Test, OncotypeDX
Corporate/ 2023-07-24
Gencurix Announces Clinical Research Res...

SEOUL,South Korea,June 4,2023-- Gencurix (KOSDAQ #229000),a leading provider of cancer molecular diagnostics,announced the release of clinic...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release